- Home
- DARE vs COCH Comparison
DARE vs COCH Comparison
Compare DARE & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DARE
- COCH
- Stock Information
- Founded
- DARE 2015
- COCH 1995
- Country
- DARE United States
- COCH United States
- Employees
- DARE N/A
- COCH N/A
- Industry
- DARE Biotechnology: Pharmaceutical Preparations
- COCH Blank Checks
- Sector
- DARE Health Care
- COCH Finance
- Exchange
- DARE Nasdaq
- COCH Nasdaq
- Market Cap
- DARE 26.3M
- COCH 31.6M
- IPO Year
- DARE N/A
- COCH N/A
- Fundamental
- Price
- DARE $2.52
- COCH $1.47
- Analyst Decision
- DARE Strong Buy
- COCH Strong Buy
- Analyst Count
- DARE 3
- COCH 2
- Target Price
- DARE $12.50
- COCH $9.25
- AVG Volume (30 Days)
- DARE 452.0K
- COCH 25.9K
- Earning Date
- DARE 08-11-2025
- COCH 08-11-2025
- Dividend Yield
- DARE N/A
- COCH N/A
- EPS Growth
- DARE N/A
- COCH N/A
- EPS
- DARE N/A
- COCH N/A
- Revenue
- DARE $25,909.00
- COCH $212,000.00
- Revenue This Year
- DARE $99,756.91
- COCH $8.04
- Revenue Next Year
- DARE $119.77
- COCH $15.39
- P/E Ratio
- DARE N/A
- COCH N/A
- Revenue Growth
- DARE N/A
- COCH N/A
- 52 Week Low
- DARE $2.11
- COCH $1.21
- 52 Week High
- DARE $4.60
- COCH $3.99
- Technical
- Relative Strength Index (RSI)
- DARE 41.75
- COCH 48.45
- Support Level
- DARE $2.37
- COCH $1.40
- Resistance Level
- DARE $2.54
- COCH $1.58
- Average True Range (ATR)
- DARE 0.14
- COCH 0.10
- MACD
- DARE -0.00
- COCH 0.01
- Stochastic Oscillator
- DARE 59.56
- COCH 43.74
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.